Fertility-preserving surgical procedures for patients with gynecologic malignancies.
Gynecologic malignancies often affect young women who are at the peak of their reproductive potential. The treatment for gynecologic malignancies often consists of removal of the ovaries or uterus, affecting the future fertility of these patients. Advances in surgical management have allowed patients to undergo more conservative treatment with preservation of their fertility. This review summarizes fertility-sparing surgical procedures for patients with gynecologic malignancies evaluating the role of radical trachelectomy and ovarian transposition in cervical cancer, hormonal therapy and hysteroscopic resection in endometrial cancer, and conservative surgery in ovarian cancer.
Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Nabila
N
Rasool
Peter G
PG
Rose
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D002584:Cervix Uteri / Q000473:pathology / Q000601:surgery; D019092:Conization; D005260:Female; D005298:Fertility; D005833:Genital Neoplasms, Female / Q000628:therapy*; D031901:Gestational Trophoblastic Disease; D013509:Gynecologic Surgical Procedures; D006801:Humans; D007436:Intrauterine Devices, Medicated; D009361:Neoplasm Invasiveness; D009373:Neoplasms, Germ Cell and Embryonal / Q000628:therapy; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage; D011372:Progestins / Q000008:administration & dosage; D018312:Sex Cord-Gonadal Stromal Tumors / Q000628:therapy; D014328:Trophoblastic Neoplasms / Q000628:therapy; D002578:Uterine Cervical Dysplasia / Q000628:therapy
D018931:Antineoplastic Agents, Hormonal; D011372:Progestins; D011374:Progesterone